Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 14/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 12/20 | 0.63 |
| ▸ | OPRD1 | P41143 | 12/20 | 0.63 |
| ▸ | OPRK1 | P41145 | 12/20 | 0.63 |
| ▸ | CCR1 | P32246 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24422204 | 0.84 | CYP2D6 (0.58) | OPRL1OPRM1OPRD1OPRK1CYP2D6 | |
| SCHEMBL25453172 | 0.84 | OPRL1 (0.65) | OPRL1OPRM1OPRD1OPRK1CYP2D6 | |
| SCHEMBL10057646 | 0.83 | OPRM1 (0.63) | OPRL1OPRM1OPRD1OPRK1CCR1 | |
| SCHEMBL5962422 | 0.83 | OPRM1 (0.63) | OPRL1OPRM1OPRD1OPRK1CCR1 | |
| SCHEMBL7696081 | 0.82 | OPRL1 (0.73) | OPRL1OPRM1OPRD1OPRK1CYP2D6 | |
| SCHEMBL23384021 | 0.81 | OPRM1 (0.67) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL19491063 | 0.81 | OPRL1 (0.53) | OPRL1OPRM1OPRD1OPRK1CCR1 | |
| SCHEMBL578244 | 0.80 | OPRM1 (0.55) | OPRL1OPRM1OPRD1OPRK1CCR1 | |
| SCHEMBL23384014 | 0.80 | OPRL1 (0.68) | OPRL1OPRM1OPRD1OPRK1CYP2D6 | |
| SCHEMBL19491346 | 0.80 | OPRL1 (0.43) | OPRL1OPRM1OPRD1OPRK1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | NATIONAL INSTITUTES OF HEALTH | 2023-05-11 | — | — | US | disclosed |
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | NATIONAL INSTITUTES OF HEALTH | 2023-05-11 | — | — | US | disclosed |
| WO-2021202600-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | HAVCR2, CD44, ENGASE | OPRL1 4829/4885OPRM1 4657/4885OPRD1 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.